When cells cycle fast, cancer gets a jumpstart

December 18, 2019

The progression of cancer has been studied extensively, and the key steps in this journey have been well mapped, at least in some solid tumors: Lesions to genes that confer risk of cancer accumulate and alter normal cell behaviors, giving rise, scientists believe, to early stage cancer cells that eventually swamp normal cells and become deadly.

But Yale researchers have now identified another bit of cellular chicanery that jumpstarts cancer. In at least one form of blood cancer, they report Dec. 18 in the journal Nature Communications, cells with cancer-causing gene lesions can remain normal and healthy -- until cell division, or cycling, speeds up.

"Many people with cancer-causing genes remain healthy for many, many years,'' said senior author Shangqin Guo, assistant professor of cell biology and a researcher at the Yale Stem Cell Center. "So, in these cases, you have to wonder whether the dogma 'mutations cause cancer' is the complete truth."

Guo and first author Xinyue Chen, a graduate student in Guo's lab, wanted to focus on the role of cell cycling speed, which varies in normal tissue, on the formation of cancer. They studied acute myeloid leukemia (AML), an aggressive type of blood cancer that carries the lowest number of mutations among human cancers. They introduced a known leukemia-causing mutation, MLL-AF9, into the genomes of mice and tracked individual blood cells for signs of cancer. While the great majority of cells remained normal, the few cells that divided most quickly almost always became malignant.

"When a normal cell that divides quickly meets MLL-AF9, this combination creates a monster cell that is stuck in a state of perpetual fast division," Guo said. "Their more slowly cycling counterparts remain normal and do not display the malignant cancer traits, even in the presence of cancer-causing mutations."

Understanding how a normal cell crosses over to the dark side has important implications.

For example, the researchers said, certain infections can trigger a proliferation of rapidly-dividing cells to fight the pathogens, perhaps opening the door to cancer.

Also, stem cells generally experience functional decline during aging, which requires healthier stem cells to divide more quickly to repair damaged tissue. The increased proliferation may provide an explanation of why people become more susceptible to cancer as they age, the scientists said.
The work was funded by a New Innovator Award from National Institutes of Health, Gilead Sciences, and the Hood Foundation. The researchers said they are also grateful for the support from the Kutnick Family Foundation.

Yale University

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.